Immucor blood bank reagents
Ended Awarded Last action
- Contract number
- N6890817F0108
- Awardee
-
Immucor Inc. UEI KV8AGJX7NMZ7
- Awarding agency
-
Bureau of Medicine and Surgery
Department of the Navy, Department of Defense
- Obligated
- $27,497
Award facts
- Contract value 19% obligated
- $145,046.75 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Norcross, GA, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $7,564 | |
| Funding Only Action | $25,205 | |
| Other Administrative Action | $2,291 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $27,497 | |
| Exercise an Option | $0 | |
| Exercise an Option | $27,497 | |
| Exercise an Option | $27,497 | |
| Original award | $27,497 |
About this award
Immucor Inc. was awarded a delivery order valued at $145,046.75 for blood bank reagents by the Bureau of Medicine and Surgery (BUMED), the medical command within the Department of Defense. This firm fixed-price contract, issued under the General Services Administration Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests, became effective on October 1, 2017, with an ultimate completion date of September 30, 2022. The contract carries no set-aside designation and specifies Norcross, Georgia as the place of performance, where Immucor maintains its headquarters and primary operations.
As a specialized manufacturer of in vitro diagnostic products and blood banking solutions, Immucor delivers critical medical supplies supporting transfusion and transplantation compatibility testing across federal healthcare networks. This delivery order aligns with BUMED's mission to provide comprehensive medical services to military personnel and their families. Immucor's established federal contracting history demonstrates its capability to supply blood banking reagents, testing equipment, and related consumables consistently across multiple Defense and Veterans Affairs healthcare facilities, making the company a reliable provider for the specialized diagnostic products required by military medical operations.
Quick answers
Who was awarded contract N6890817F0108?
N6890817F0108 was awarded to Immucor Inc. by Bureau of Medicine and Surgery (Department of the Navy) on October 1, 2017.
How much is contract N6890817F0108 worth?
The government has obligated $27,497 on N6890817F0108. Its current value, with exercised options, is $145,047.
Is contract N6890817F0108 an order under another contract?
Yes. N6890817F0108 is a delivery order under V797D70110, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract N6890817F0108 competed?
The extent of competition for N6890817F0108 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award